Research Article
DNA Methylation Modification Regulator-Mediated Molecular Clusters and Tumor Metabolic Characterization in Prostate Cancer
Table 1
Association of DMS with somatic variants.
| | Gene symbol | High DMS (%) | Low DMS (%) | value |
| | SPOP | 44 (19%) | 2 (1%) | | | TP53 | 12 (5%) | 38 (16%) | | | TTN | 12 (5%) | 29 (12%) | | | CSMD1 | 1 (0%) | 8 (3%) | | | KMT2D | 16 (7%) | 7 (3%) | | | FAT3 | 2 (1%) | 9 (4%) | | | LRP1B | 4 (2%) | 10 (10%) | | | FOXA1 | 14 (6%) | 8 (3%) | | | SYNE1 | 5 (2%) | 11 (5%) | | | PTEN | 5 (2%) | 11 (5%) | | | MUC17 | 3 (1%) | 8 (3%) | | | CSMD3 | 5 (2%) | 9 (4) | | | MUC16 | 7 (3%) | 11 (5%) | | | OBSCN | 4 (2%) | 7 (3%) | | | USH2A | 4 (2%) | 7 (3%) | | | HMCN1 | 7 (3%) | 5 (2%) | | | ATM | 6 (3%) | 9 (4%) | | | SPTA1 | 7 (3%) | 9 (4%) | | | KMT2C | 9 (4%) | 10 (4%) | | | RYR2 | 6 (3%) | 7 (3%) | |
|
|
